Neurol. praxi. 2016;17(4):263-267

Friedrich Heinrich Lewy, his corpuscles and their illnesses

prof. MUDr. Petr Kaňovský, CSc., MUDr. Kateřina Menšíková, Ph.D., prof. MUDr. Ing. Petr Hluštík, Ph.D.
Neurologická klinika LF UP a FN, Olomouc

Friedrich Heinrich Lewy (1885–1950), the man, who discovered Lewy bodies, pathological hallmark of neurodegenerative synucleinopathies,

live dout an adveturous life. After serving in the German Army in the First World War, he became a professor

of neurology and psychiatry. He had build a modern neuroscience institute in Berlin; after that has been forced to escape his

country for Nazi repressions. He put down root in USA, served in the US Army and became a professor of neuroanatomy and

neuropathology. The role of bodies, which bear his name, in the pathophysiology of parkinsonian neurodegeneration has been

elucidated nearly half a century after his death.

Keywords: Friedrich Heinrich Lewy, Lewy bodies, Parkinson´s disease

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňovský P, Menšíková K, Hluštík P. Friedrich Heinrich Lewy, his corpuscles and their illnesses. Neurol. praxi. 2016;17(4):263-267.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aarsland D, Londos E, Ballard C. Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr 2009; 21: 216-219 Go to original source... Go to PubMed...
    2. Alafuzoff A, Ince PG, Arzberger T, et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009; 117: 635-652. Go to original source... Go to PubMed...
    3. Andrade LAF; Selikhova M, Lees AJ. Konstantin N. Tretiakoff in Brazil. Arq Neuropsiquiatr 2009; 67: 322-327. Go to original source... Go to PubMed...
    4. Berg D, Postuma R, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord 2014; 29: 454-462. Go to original source... Go to PubMed...
    5. Bhidayasiri R, Reichmann H. Different diagnostic criteria for Parkinson disease: what are the pitfalls? J Neural Transm 2013; 120: 619-625. Go to original source... Go to PubMed...
    6. Braak H, Ghebremedhin E, Rüb U et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121 - 34 Go to original source... Go to PubMed...
    7. Braak H, Müller CM, Rüb U, et al. Pathology associated with sporadic Parkinson's disease - where does it end? J Neural Transm Suppl. 2006; 70: 89-97. Go to original source... Go to PubMed...
    8. Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev 2011; 91: 1161 - 218 Go to original source... Go to PubMed...
    9. Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y. Evidence in favor of Braak staging of Parkinson's disease. Mov Disord 2010; 25(Suppl.1): S78-82. Go to original source... Go to PubMed...
    10. Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's diaease. J Neuropathol Exp Neurol 1965; 24: 398-414. Go to original source...
    11. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-707. Go to original source... Go to PubMed...
    12. Farníková K, Bareš M, Nestrašil I, et al. Parkinsonské fenotypy - na cestě k nové nozologii atypických parkinsonských syndromů. Ces Slov Neurol N 2011; 74: 641-653.
    13. Galpern WR, Lang AE. Interface between tauopathies and synucleinopathies: a tale fo two proteins. Ann Neurol 2006; 59: 449-458. Go to original source... Go to PubMed...
    14. Gibb WRG; Poewe WH. The centenary of Friedrich H. Lewy 1885 - 1950. Neuropathol Appl Neurobiol 1986; 12: 217-222. Go to original source... Go to PubMed...
    15. Gibb WRG. Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgr Med J 1988; 64: 345-351. Go to original source... Go to PubMed...
    16. Greenfield JG, Bosanquet FD. The brainstem lesions in parkinsonism. J Neurol Neurosurg Psychiatr 1953; 16: 213-226. Go to original source... Go to PubMed...
    17. Holdorff B. Friedrich Heinrich Lewy (1885-1950) and his work. J Histor Neurosci 2002; 11: 19-28. Go to original source... Go to PubMed...
    18. Holdorff B, Rodrigues da Silva A, Dodel R. Centenary of Lewy bodies (1912-2012). J Neural Transm 2013; 120: 509-516. Go to original source... Go to PubMed...
    19. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialis movement disorder service. Brain 2002; 125: 861-870. Go to original source... Go to PubMed...
    20. Jellinger K. Formation and development of Lewy pathology: a critical update. J Neurol 2009; 256(Suppl. 1): S270-279. Go to original source... Go to PubMed...
    21. Jellinger K. Interactions between alpha-synuclein and other proteins in neurodegenerative disorders. Scientific World Journal 2011; 11: 1893-1907. Go to original source... Go to PubMed...
    22. Jellinger K. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012; 27: 8-30. Go to original source... Go to PubMed...
    23. Kosaka K, Oyanagi S, Matsushita M, Hori A. Presenile dementia with Alzheimer-, Pick- and Lewy-Body changes. Acta Neuropath 1976; 36: 221-233. Go to original source... Go to PubMed...
    24. Kosaka K. Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol 1978; 42: 127-134. Go to original source... Go to PubMed...
    25. Kosaka K. Latest concept of Lewy body disease. Psychiatry Clin Neurosci 2014; 68: 391-394. Go to original source... Go to PubMed...
    26. Lees AJ, Selikhova M, Andrade L, et al. The black stuff and Konstantin Nikolaevich Tretiakoff. Mov Disord 2008; 23: 777-783. Go to original source... Go to PubMed...
    27. Lewy FH. Paralysis agitans. Part I: Pathologische Anatomie. In: Lewandowski M. (ed) Handbuch der Neurologie, Vol. III, spez. Neurol. II. Julius Springer; Berlin 1912: 920-933.
    28. McKeith I, Mintzer J, Aarsland D, et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3: 19-28. Go to original source... Go to PubMed...
    29. McKeith I, Dickson D, Lowe J, et al. Diagnosis and management of dementia with lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872. Go to original source... Go to PubMed...
    30. McKeith I. DLB and PDD: the same or different? Is there a debate? Int Psychogeriatr 2009; 21: 220-224. Go to original source... Go to PubMed...
    31. Menšíková K, Kaiserová M, Kaňovský P, et al. Proměnlivá tvář parkinsonské neurodegenerace. Ces Slov Neurol N 2013; 76: 26-34.
    32. Puschmann A, Bhidayasiri R, Weiner W. Synucleinopathies from bench to bedside. Park Relat Disord 2012; 18(Suppl. 1): S24-S27. Go to original source... Go to PubMed...
    33. Rodrigues da Silva A, Geldsetzer F, Holdorff B et al. Who was the man who discovered the "Lewy bodies"? Mov Disord 2010; 25: 1765-1773. Go to original source... Go to PubMed...
    34. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-840. Go to original source... Go to PubMed...
    35. Stern MB, Lang A, Poewe W. Toward a redefinition of Parkinson's disease. Mov Disord 2012; 27: 54-60. Go to original source... Go to PubMed...
    36. Tsuboi A, Dickson D. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Park Relat Disord 2005; 11: S47-S51. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.